Empagliflozin 25 mg / Linagliptin 5 mg Tablet is a combination medication used to treat type 2 diabetes. Empagliflozin helps lower blood sugar by promoting glucose excretion through the kidneys, while Linagliptin enhances insulin production and lowers glucagon levels. Together, they improve blood sugar control and reduce the risk of heart-related complications. This combination is especially helpful for patients with type 2 diabetes who are at risk for cardiovascular issues.
Find products similar to 25/5mg Empagliflozin Linagliptin Tablet, Packaging Size: 10x10, 25 Mg
Interested in this product?Get Latest Price from the seller
About the Company
GST Registration Date
02-07-2021
Legal Status of Firm
Limited Company
Nature of Business
Trader - Retailer
Annual Turnover
0 - 40 L
IndiaMART Member Since
Apr 2025
GST
07AACCW8961H1ZW
Wellmark Remedies Private Limited is a major company in the health sector. It is said that the company has been diligently committed to diverse healthcare services and solutions for citizens worldwide. The company promoted excellence and quality, as well as the welfare of patients, thus giving it a position as a trustworthy organisation in the entire healthcare industry. Wellmark Remedies Private Limited continues to invest in technological innovation and future technologies that will define the future of healthcare. The firm embraces digital health solutions, artificial intelligence, genomics, and other innovative technologies that evolve customised and targeted treatment options, elaborate on disease management strategies and enhance service delivery in healthcare. Wellmark Remedies Private Limited offers a well-rounded portfolio of healthcare products. All these products fall into the category of different therapeutic areas, including prescription drugs, over-the-counter drugs, medical equipment, diagnostic tools, and so on. Each of the above products is well-designed, analytically tested, and highly valued for its safety and efficacy.
